Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
Open accessThe DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.
Abstract
Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–234 of 234
The Combined Use of Mesenchymal Stromal Cells and Scaffolds for Bone Repair
Ciapetti, G., Granchi, D., & Baldini, N. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799859648 · Cited by 61
Concise Review: Identifying Limbal Stem Cells: Classical Concepts and New Challenges
Joe, A. W., & Yeung, S. N. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0137 · Cited by 61 · cited 1×
“They have also been isolated from other adult tissues such as adipose tissue [10], skin [11], lung [12], synovial membrane [13], dental pulp [14], nasal olfactory mucosa [15], breast milk [16], scalp tissue [17], muscle [18], periosteum [19], corneal limbus [20], peripheral blood [21], endometrial and menstrual blood…”
BackgroundZanotti, L., Angioni, R., Calì, B., Soldani, C., Ploia, C., Moalli, F., Gargesha, M., D’Amico, G., Elliman, S. J., Tedeschi, G., et al. (2016) · Leukemia · doi:10.1038/leu.2016.33 · Cited by 61 · cited 1×
“Recently, an extensive proteomic analysis of the MSC-CM stimulated with inflammatory cytokines led to the identification of tissue inhibitor of metalloproteinase-1 (TIMP-1) as the molecule responsible for the antiangiogenic effects of MSCs [122].”
BackgroundPreda, M. B., Rønningen, T., Burlacu, A., Simionescu, M., Moskaug, J. Ø., & Valen, G. (2014) · Stem Cells · doi:10.1002/stem.1687 · Cited by 60 · cited 1×
“reduce scar formation [99,100] and improve the long-term ejection fraction when administered early or prior to adverse remodeling in experimental models of myocardial infarction [100–102].”
BackgroundVieira, N. M., Zucconi, E., Júnior, C. R. B., Secco, M., Suzuki, M. F., Bartolini, P., Vainzof, M., & Zatz, M. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9187-5 · Cited by 54 · cited 1×
“Differences in therapeutic potential according to MSC origin have been demonstrated [23,162,163].”
BackgroundDuggal, S., & Brinchmann, J. E. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22637 · Cited by 54 · cited 1×
“The patient’s age and clinical characteristics influence the optimal culture conditions for clinical scale production of human MSCs [30,31].”
BackgroundAttar‐Schneider, O., Zismanov, V., Drucker, L., & Gottfried, M. (2015) · Tumor Biology · doi:10.1007/s13277-015-4304-3 · Cited by 48 · cited 1×
“effects on non-small cell lung cancer cells [126] or stimulatory effects on myeloma cells [127], whereas adipose stem cell conditioned medium (ADSC-CM) has no effect on human glioblastoma cancer stem cell subpopulations [128].”
BackgroundGrote, K., Petri, M., Liu, C., Jehn, P., Spalthoff, S., Kokemüller, H., Luchtefeld, M., Tschernig, T., Krettek, C., Haasper, C., et al. (2013) · European Cells and Materials · doi:10.22203/ecm.v026a05 · Cited by 46
Conditioned medium derived from umbilical cord mesenchymal stem cells regenerates atrophied muscles
Kim, M. J., Kim, Z.-H., Kim, S., & Choi, Y. (2016) · Tissue and Cell · doi:10.1016/j.tice.2016.06.010 · Cited by 46 · cited 3×
“BMMSCs: Bone marrow-derived mesenchymal stem cells; ADSCs: Adipose-derived stem cells; DPSC: Dental pulp stem cells; WJMSCs: Umbilical cord Wharton's Jelly mesenchymal stem cells; hUCESCs: Human uterine cervical stem cells; UCPVCs: Umbilical cord perivascular cells; PDLSCs: Periodontal ligament stem cells.”
BackgroundThe Immunoregulatory Activity of Mesenchymal Stem Cells: ‘State of Art’ and ‘Future Avenues’
Fierabracci, A., Fattore, A. D., & Muraca, M. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160627112827 · Cited by 46 · cited 1×
“It has been widely shown that MSCs are capable of affecting activation and proliferation of all immune cell types [77].”
BackgroundKowal‐Bielecka, O., Distler, O., Neidhart, M., K�nzler, P., Rethage, J., Nawrath, M., Carossino, A. M., Pap, T., M�ller-Ladner, U., Michel, B. A., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200108)44:8<1865::aid-art325>3.0.co;2-m · Cited by 44
Pasero, C., Barbarat, B., Just‐Landi, S., Bernard, A., Aurran, T., Rey, J., Eldering, E., Truneh, A., Costello, R. T., & Olive, D. (2009) · European Journal of Immunology · doi:10.1002/eji.200939069 · Cited by 39
Skin-Derived Mesenchymal Stem Cells: Isolation, Culture, and Characterization
Orciani, M., & Primio, R. D. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-330-5_21 · Cited by 38 · cited 1×
“They have also been isolated from other adult tissues such as adipose tissue [10], skin [11], lung [12], synovial membrane [13], dental pulp [14], nasal olfactory mucosa [15], breast milk [16], scalp tissue [17], muscle [18], periosteum [19], corneal limbus [20], peripheral blood [21], endometrial and menstrual blood…”
BackgroundAltanerova, U., Benejova, K., Altanerová, V., Tyčiaková, S., Rychlý, B., Szomolányi, P., ČIAMPOR, F. J., Cihova, M., Repiská, V., Ondičová, K., et al. (2016) · Neoplasma · doi:10.4149/neo_2016_611 · Cited by 38
Collin, M., Linge, H. M., Bjartell, A. S., Giwercman, A., Malm, J., & Egesten, A. (2008) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2008.08.003 · Cited by 36
The biology of incipient, pre-invasive or intraepithelial neoplasia
Grizzle, W. E., Srivastava, S., & Manne, U. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0172 · Cited by 35 · cited 1×
“Furthermore, inflammation and regeneration are closely linked in this setting, which constitute a standard model of carcinogenesis [144].”
BackgroundAnalysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment
Onzi, G. R., Ledur, P. F., Hainzenreder, L. D., Bertoni, A. P. S., Silva, A. O., Lenz, G., & Wink, M. R. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.03.299 · Cited by 35 · cited 1×
“effects on non-small cell lung cancer cells [126] or stimulatory effects on myeloma cells [127], whereas adipose stem cell conditioned medium (ADSC-CM) has no effect on human glioblastoma cancer stem cell subpopulations [128].”
BackgroundLu, P., Li, L., Wu, Y., Mukaida, N., & Zhang, X. (2008) · PubMed · Cited by 34
Famian, M. H., Montazersaheb, S., & Montaseri, A. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.016 · Cited by 34 · cited 1×
“Lung injury BMMSCs [55] Myocardial infarction ADSCs [56] Cerebral injury/ischemia/stroke BMMSCs [57] Spinal cord injury BMMSCs [58] Prevention of muscular degeneration ADSCs [59] Acute and chronic hind limb ischemia ADSCs [60] Skin wound healing ADSCs [61] Colitis Amniotic fluid [62] Acute liver injury/failure Amnioti…”
BackgroundHo, J. C.-Y., Lai, W., Li, M., Au, K., Yip, M.-C., Wong, N. L. Y., Ng, E. S.-K., Lam, F. F. Y., Siu, C., & Tse, H. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2304 · Cited by 33
Schneider, J., Eiró, N., Pérez-Fernández, R., Martínez-Ordóñez, A., & Vizoso, F. J. (2016) · Europe PMC (PubMed Central) · Cited by 32
Self-citationFunctional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma
Santangelo, L., Battistelli, C., Montaldo, C., Citarella, F., Strippoli, R., & Cicchini, C. (2017) · BioMed Research International · doi:10.1155/2017/2931813 · Cited by 32
Won, H. S., Kim, Y. A., Lee, J. S., Jeon, E. K., An, H. J., Sun, D. S., Ko, Y. H., & Kim, J. S. (2013) · Cancer Investigation · doi:10.3109/07357907.2013.826239 · Cited by 31
Role of Microvesicles From Bone Marrow Mesenchymal Stem Cells in Acute Pancreatitis
Yin, G., Hu, G., Wan, R., Yu, G., Cang, X., Xiong, J., Ni, J., Hu, Y., Xing, M., Fan, Y., et al. (2016) · Pancreas · doi:10.1097/mpa.0000000000000694 · Cited by 30
Ranganath, S. H., Tong, Z., Levy, O., Martyn, K., Karp, J. M., & Inamdar, M. S. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.05.003 · Cited by 29
Kim, J., Lee, J. H., Yeo, S. M., Chung, H., & Chae, J. (2013) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-013-9687-0 · Cited by 28
Silver, D. F., Hempling, R. E., Piver, M. S., & Repasky, E. A. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5782 · Cited by 26
Jang, Y. J., An, S. Y., & Kim, J. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.2.012 · Cited by 25 · cited 3×
“BMMSCs: Bone marrow-derived mesenchymal stem cells; ADSCs: Adipose-derived stem cells; DPSC: Dental pulp stem cells; WJMSCs: Umbilical cord Wharton's Jelly mesenchymal stem cells; hUCESCs: Human uterine cervical stem cells; UCPVCs: Umbilical cord perivascular cells; PDLSCs: Periodontal ligament stem cells.”
BackgroundLin, W., Oh, S., Choo, A. B. H., & George, A. J. T. (2011) · Cytotherapy · doi:10.3109/14653249.2011.635853 · Cited by 23
Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation
Marcus, H., Attar‐Schneider, O., Dabbah, M., Zismanov, V., Tartakover‐Matalon, S., Lishner, M., & Drucker, L. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.03.003 · Cited by 21 · cited 1×
“effects on non-small cell lung cancer cells [126] or stimulatory effects on myeloma cells [127], whereas adipose stem cell conditioned medium (ADSC-CM) has no effect on human glioblastoma cancer stem cell subpopulations [128].”
BackgroundFierabracci, A., Fattore, A. D., Muraca, M., Delfino, D. V., & Muraca, M. (2016) · Current Drug Targets · doi:10.2174/1389450116666150722140633 · Cited by 19 · cited 1×
“Pre-clinical studies on animal models have shown a suppressive effect on both innate and adaptive immunity [72,73].”
Background(2015) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000264 · Cited by 14
Characterization of the Human Smooth Muscle Cell Secretome for Regenerative Medicine
Justewicz, D. M., Shokes, J. E., Reavis, B., Boyd, S. A., Burnette, T. B., Halberstadt, C. R., Spencer, T. E., Ludlow, J. W., Bertram, T. A., & Jain, D. (2012) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0054 · Cited by 12 · cited 1×
“Both of these components may be capable of independently triggering regeneration and repair as well as of mediating the de novo organogenesis of tissue-engineered organs ex vivo [43,54].”
BackgroundWarrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Research works printed but not linked: 2
- Luyten, 2001, Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age, Arthritis Rheum., 44, 85, 10.1002/1529-0131(200101)44:1<85::AID-ANR12>3.0.CO;2-6 · doi:10.1002/1529-0131(200101)44:1<85::aid-anr12>3.0.co;2-6
- Litwack, G. (2008). Human Biochemistry and Disease, Academic Press.
Cited by
Clinical applications of stem cell-derived exosomes
Tan, F., Li, X., Wang, Z., Li, J., Shahzad, K., & Zheng, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01704-0 · Cited by 708
“11 In other words, stem cell-derived exosomes (SC-Exo) inherit similar therapeutic effects from their parental cell of origin, e.g., anti-in fl ammation, immunomodulation and tissue regeneration.”
BackgroundConcise Review: Mesenchymal Stem Cells: From Roots to Boost
Andrzejewska, A., Lukomska, B., & Janowski, M. (2019) · Stem Cells · doi:10.1002/stem.3016 · Cited by 611
Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning
Ferreira, J. R., Teixeira, G. Q., Santos, S. G., Barbosa, M. A., Almeida-Porada, G., & Gonçalves, R. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02837 · Cited by 572
Harrell, C., Fellabaum, C., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019) · Cells · doi:10.3390/cells8050467 · Cited by 501
“When MSCs are cultured in the presence of high concentration of inflammatory cytokines and engraft in the inflammatory microenvironment, they start to produce anti-angiogenic molecules in order to prevent migration of circulating leucocytes in the inflamed tissues [37].”
BackgroundInfluentialMesenchymal stromal/stem cell (MSC)-Derived exosomes in clinical trials
Lotfy, A., AboQuella, N. M., & Wang, H. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03287-7 · Cited by 482
“Additionally, several preclinical studies have reported that MSC-Exos therapy is superior compared to cell therapy in terms of safety, efficacy, and versatility [95, 96].”
Background
Metadata
- Authors
- Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R.
- Affiliations
- Fundación Hospital de Jove (ES)
- Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33290 Gijón, Spain
- Department of Obstetrics & Gynecology, C/Ramon y Cajal 7, University of Valladolid, 47005 Valladolid, Spain
- Department of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Santiago de Compostela, Spain
- Corresponding author
- Vizoso, Francisco
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-25
- Volume
- 18
- Issue
- 9
- Pages
- 1852
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5618501
- OpenAlex
- W2746710261
- Cited by
- 1,363
- References
- 235
- Citations by year
- 2026: 142 · 2025: 165 · 2024: 153 · 2023: 182 · 2022: 186 · 2021: 178 · 2020: 158 · 2019: 130 · 2018: 62 · 2017: 6
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Council
- European Regional Development Fund (SAF2015-69221-R)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, cell-free therapy, conditioned medium, exosomes, regenerative medicine, stem cell therapy, quality control, regulatory requirements
- MeSH terms
- Clinical Studies as Topic, Animals, Humans, Stem Cells, Culture Media, Conditioned, Regenerative Medicine, Mesenchymal Stem Cell Transplantation, Cell-Derived Microparticles, Exosomes, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.